Article
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2010
Doherty Jennifer A, Rossing Mary Anne, Cushing-Haugen Kara L, Chen Chu, Van Den Berg David J, Wu Anna H, Pike Malcolm C, Ness Roberta B, Moysich Kirsten, Chenevix-Trench Georgia, Beesley Jonathan, Webb Penelope M, Chang-Claude Jenny, Wang-Gohrke Shan, Goodman Marc T, Lurie Galina, Thompson Pamela J, Carney Michael E, Hogdall Estrid, Kjaer Susanne Kruger, Hogdall Claus, Goode Ellen L, Cunningham Julie M, Fridley Brooke L, Vierkant Robert A, Berchuck Andrew, Moorman Patricia G, Schildkraut Joellen M, Palmieri Rachel T, Cramer Daniel W, Terry Kathryn L, Yang Hannah P, Garcia-Closas Montserrat, Chanock Stephen, Lissowska Jolanta, Song Honglin, Pharoah Paul D P, Shah Mitul, Perkins Barbara, McGuire Valerie, Whittemore Alice S, Di Cioccio Richard A, Gentry-Maharaj Aleksandra, Menon Usha, Gayther Simon A, Ramus Susan J, Ziogas Argyrios, Brewster Wendy, Anton-Culver Hoda, Pearce Celeste Leigh
Abstract excerpt
We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls...
Read the complete abstract on PubMed